FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

473311000001105: Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17523301000001117 Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37778301000001114 Magnapen 500mg powder for solution for injection vials (Wockhardt UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Is a Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin sodium false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Is a Magnapen true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has specific active ingredient Ampicillin sodium true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) 10 vial Is pack of False Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) 10 vial Has AMP True Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start